市場調查報告書
商品編碼
1470779
電生理學市場:按產品、適應症和最終用戶分類 - 全球預測 2024-2030Electrophysiology Market by Product, Indication, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年電生理學市場規模為1.9764億美元,預計2024年將達2.2357億美元,2030年將達4.8205億美元,複合年成長率為13.58%。
電生理學是生理學的一個分支,重點是活細胞和組織的電特性。電生理學市場涵蓋用於診斷和治療心臟電活動的設備和技術的研究、開發、製造和銷售的各個方面。這包括心電圖 (ECG)、電生理學研究 (EPS) 和消融設備等診斷測試。心房顫動的增加和對心導管電氣燒灼術的偏好正在推動市場成長。對微創治療的需求不斷成長也在市場擴張中發揮重要作用。手術和設備高成本、缺乏熟練的專業人員以及定義鬆散的醫療改革是影響電生理學市場的限制因素。電生理學設備的技術進步以及電生理學中 3D 繪圖系統的引入預計將為電生理學市場帶來重大商機。
主要市場統計 | |
---|---|
基準年[2023] | 1.9764億美元 |
預測年份 [2024] | 22357萬美元 |
預測年份 [2030] | 4.8205億美元 |
複合年成長率(%) | 13.58% |
由於產品的高精度和詳細的測繪能力,對高密度測繪導管的需求正在增加
在電生理學 (EP) 中,接取裝置是一種進入血管進行診斷或治療的儀器。包括導引鞘、導管導引線等,有助於將導管插入和引導至心臟。電生理消融導管是用於消融或破壞引起心律不整的小面積心臟組織的專用儀器。我們使用多種能源來源,包括射頻、冷凍療法和雷射。冷凍消融導管是一種專門的電生理學設備,它使用極低的溫度來惰性心臟組織並恢復正常的心律。此過程通常使用低溫物質(例如液態氮或氧化亞氮)來去除問題區域。在電生理學中,雷射消熔系統用於以最小的附帶損傷進行精確消融。雷射發出單色光能,被目標組織吸收,導致溫度升高並隨後破壞組織。微波消融系統使用微波頻率的電磁波在心臟組織內產生熱。這種熱量會導致凝固性壞死,有效地消除異常電活動的根源。用於導航的先進測繪附件有助於複雜的消融手術。這些設備,包括標測導管和軟體,可以在心室內進行精確的可視化和導航。射頻 (RF) 消融導管是心導管電氣燒灼術治療的標準工具。射頻導管將射頻能源傳送到導管尖端加熱組織並引起局部消融。
診斷電生理學導管用於繪製心臟的電活動圖,以確定心律不整的原因。它們有各種形狀和尺寸,以滿足不同的解剖學要求。先進的電氣生理學診斷導管是用於繪製和分析心臟電活動的最先進工具。這些高度敏感的導管提供即時資料,能夠精確定位心律不整發作部位。傳統的電氣生理學診斷導管一直是心律不整研究的基石。這些導管比更先進的導管簡單,用於心臟電導的基本繪圖。超音波電氣生理學診斷導管採用心內回波 (ICE) 技術,可提供心臟內部即時、高解析度的影像。這些導管使用超音波來可視化心臟的結構和血流,幫助評估複雜的心律不整並指導介入手術。
EP 測試設備包括多種設備,例如測繪和記錄系統、消融產生器和心內回波系統。這些測試設備對於所有電生理學程序的成功至關重要。 3D 繪圖系統是 EP 實驗室使用的先進工具,用於即時創建心室的3D模型。使用這個模型,醫生可以高精度地可視化和導航心臟的結構,從而可以精確繪製心律不整期間的電活動並指導治療性介入,包括消融手術。電生理學記錄系統是 EP 實驗室的基礎技術,提供了測量和記錄心臟內電訊號的方法。電生理學遠端控制系統使用先進的磁性和機器人技術,使醫生能夠遠端控制心臟內的導管和其他設備。 X 光影像在 EP 實驗室中非常重要,可以在手術過程中可視化導管放置和解剖結構。螢光鏡檢查系統通常由螢光鏡組成,該螢光鏡提供即時影像以引導導管和其他器械在心臟脈管系統內的移動。超音波心動圖 (ICE) 系統是 EP 實驗室使用的專門超音波測試。 ICE 涉及將超音波探頭穿過脈管系統並進入心臟,提供心臟結構的詳細影像。這在經導管介入和電生理學研究等手術過程中特別有用。射頻消融術(RFA) 產生器是 EP 實驗室使用的一種設備,可將射頻能源施加到心臟組織以治療心律不整。這種能量產生熱量並導致組織有針對性的破壞,從而導致異常的電途徑。
最終用戶:由於需要在更私密和專業的環境中接受優質護理,門診手術中心 (ASC) 變得越來越受歡迎。
由於其成本效益和效率,門診手術中心 (ASC) 越來越成為電生理手術的首選。 ASC 的等待時間短且流程簡化,使其成為患者和提供者的便捷選擇。在電生理學市場中,醫院和心臟中心是傳統的主導參與者。這些中心通常提供更全面的服務,因為它們擁有更大的基礎設施和資源,包括專業人員、先進的技術以及處理複雜案件和緊急情況的能力。這些中心提供廣泛的電生理學服務,包括診斷和治療程序,並優先考慮綜合護理。對 ASC 和醫院/心臟中心的分析表明,ASC 由於其便利、高效和低成本而正在迅速成長,這使得它們對需要常規手術的患者俱有吸引力。 ASC 提供高標準的患者客製化護理,週轉時間短,可最大限度地降低成本。另一方面,選擇醫院和心臟中心是因為它們有能力處理更複雜和多樣化的病例。
區域洞察
美洲電生理學市場的特點是技術先進,包括強大的醫療基礎設施、大量的研發投資以及大量市場參與者的存在。由於人口老化和與生活方式相關的心臟病的增加,消融和診斷等電生理手術的採用越來越多。巴西和阿根廷等國家在該地區處於領先地位,因為它們改善了醫療保健設施,提高了對心律不整疾病的認知,並改善了經濟狀況,增加了獲得先進醫療服務的機會。由於醫療保健支出增加、慢性病盛行率上升以及老年人口不斷增加,亞太地區預計將成為全球成長最快的電生理學市場。中國、日本和印度等國家走在了前列,各國政府開始進行改革,以改善醫療保健的可近性並加速先進醫療技術的採用。由於高昂的醫療保健成本、完善的醫療保健系統以及日益增加的心臟疾病患病率,歐洲是歐洲、中東和非洲電生理學市場的重要貢獻者。技術進步和有利的報銷政策也支持該地區的市場成長。在經濟狀況改善和政府醫療基礎設施現代化舉措的推動下,中東和非洲是潛力開拓的新興地區。
FPNV定位矩陣
FPNV定位矩陣對於評估電生理學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對電生理學市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,以獲得市場競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1. 電生理學市場的市場規模與預測是多少?
2.在電生理學市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3. 電生理學市場的技術趨勢和法規結構是什麼?
4.電生理市場主要廠商的市場佔有率是多少?
5. 進入電生理學市場合適的型態和策略手段是什麼?
需要在更親密和專業的環境中提供優質護理
[193 Pages Report] The Electrophysiology Market size was estimated at USD 197.64 million in 2023 and expected to reach USD 223.57 million in 2024, at a CAGR 13.58% to reach USD 482.05 million by 2030.
Electrophysiology is a branch of physiology that focuses on the study of the electrical properties of biological cells and tissues. The electrophysiology market encompasses all aspects of the research, development, manufacturing, and sale of devices and technologies used for the diagnosis and treatment of electrical activities of the heart. This includes diagnostic tests such as electrocardiograms (ECG), electrophysiological studies (EPS), and ablation devices. Increasing incidences of atrial fibrillation and preference for electrophysiology catheter ablation drive the market growth. Growing demand for minimally invasive procedures also plays a significant role in market expansion. The high cost of procedures and equipment, shortage of skilled professionals, and loosely defined healthcare reforms are among the limitations affecting the electrophysiology market. Technological advancements in electrophysiology devices and the Introduction of 3D mapping systems in electrophysiology are expected to create significant opportunities for the electrophysiology market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 197.64 million |
Estimated Year [2024] | USD 223.57 million |
Forecast Year [2030] | USD 482.05 million |
CAGR (%) | 13.58% |
Product: Growing demand for high-density mapping catheters due to their enhanced precision and detailed mapping capabilities
Access devices in electrophysiology (EP) are tools that grant entry into vascular spaces to perform diagnostic or therapeutic procedures. They include introducer sheaths, guide wires, and other devices facilitating the insertion and guidance of catheters into the heart. Electrophysiology ablation catheters are specialized instruments used to ablate or destroy small areas of heart tissue that cause arrhythmias. They employ various energy sources such as radiofrequency, cryotherapy, or laser. Cryoablation catheters are specialized electrophysiology devices that utilize extreme cold temperatures to inactivate cardiac tissue and restore normal heart rhythm. The process involves using a cryogenic substance, typically liquid nitrogen or nitrous oxide, to ablate the problematic areas. Laser ablation systems are used in electrophysiology for precise ablation with minimal collateral damage. They deliver monochromatic light energy absorbed by the targeted tissue, causing a rise in temperature and subsequent tissue destruction. Microwave ablation systems use electromagnetic waves at microwave frequencies to generate heat within cardiac tissues. This heat causes coagulative necrosis, effectively eliminating the source of abnormal electrical activity. Navigational advanced mapping accessories are instrumental in complex ablation procedures. These devices, including mapping catheters and software, enable precise visualization and navigation within the heart's chambers. Radiofrequency (RF) ablation catheters are the standard tools for catheter ablation treatments. They work by emitting radiofrequency energy to heat tissue at the catheter's tip, causing focal ablation.
Diagnostic catheters in electrophysiology are designed for mapping the heart's electrical activity to identify sources of arrhythmia. They come in various shapes and sizes for different anatomical requirements. Advanced electrophysiology diagnostic catheters are state-of-the-art tools used to map and analyze electrical activity in the heart. These highly sensitive catheters provide real-time data, allowing for the precise localization of arrhythmogenic sites. Conventional electrophysiology diagnostic catheters have been the cornerstone for studying cardiac arrhythmias. They are less complex than advanced models and are used for the basic mapping of the heart's electrical conductance. Ultrasound electrophysiology diagnostic catheters incorporate intracardiac echocardiography (ICE) technology to provide real-time, high-resolution imaging inside the heart. These catheters use ultrasound waves to visualize cardiac structures and blood flow, which aids in the assessment of complex arrhythmias and in guiding interventional procedures.
EP laboratory devices encompass a range of equipment, including mapping and recording systems, ablation generators, and intracardiac echocardiography systems. These laboratory devices are integral for the success of all electrophysiology procedures. A 3D mapping system is a sophisticated tool used in an EP lab to create a real-time, three-dimensional model of the heart's chambers. Utilizing this model, physicians can visualize and navigate cardiac structures with a high level of accuracy, allowing for precise electrical activity mapping during arrhythmias and guidance of therapeutic interventions, including ablation procedures. The electrophysiology recording system serves as the foundational technology in an EP lab, providing the means to measure and record the electrical signals within the heart. Electrophysiology remote steering systems allow physicians to control catheters and other devices within the heart remotely using advanced magnetic or robotic technology. X-ray imaging is critical in the EP lab for visualizing catheter placement and anatomy during procedures. An electrophysiology X-ray system typically comprises fluoroscopy equipment, which provides real-time imaging to guide the movement of catheters and other devices within the heart's vascular system. An intracardiac echocardiography (ICE) system is a specialized form of ultrasound used within the EP lab. ICE involves threading an ultrasound probe into the heart through the vascular system to provide detailed images of heart structures. This is especially useful during procedures such as transcatheter interventions and electrophysiological studies. The radiofrequency ablation (RFA) generator is a device used in the EP lab to treat arrhythmias by applying radiofrequency energy to the heart tissue. This energy generates heat, causing targeted destruction of tissue responsible for the abnormal electrical pathways.
End-User: Rising popularity of ambulatory surgery centers (ASCs) due to the need for high-quality care in a more intimate and specialized setting
Ambulatory surgery centers (ASCs) have been increasingly preferred for electrophysiological procedures due to their cost-effectiveness and efficiency. ASCs offer a convenient alternative for both patients and healthcare providers with shorter wait times and streamlined processes. Hospitals and cardiac centers are the traditional and dominant players in the electrophysiology market. They typically offer more comprehensive services due to their larger infrastructure and resources, including specialized staff, advanced technology, and the capacity to handle complex cases and emergencies. These centers prioritize integrated care with a wide spectrum of electrophysiological services, including both diagnostic and therapeutic procedures. In analyzing ASCs and hospitals & cardiac centers, ASCs are growing rapidly due to their convenience, efficiency, and lower costs, making them attractive for patients requiring routine procedures. They are often chosen for their high standard of personalized patient care and quick turnover times, which aids in cost minimization. Hospitals and cardiac centers, on the other hand, are selected for their ability to manage more complex and diverse cases.
Regional Insights
The electrophysiology market in the Americas is characterized by technological advancements with a robust healthcare infrastructure, substantial R&D investments, and the presence of majority market players. The adoption of electrophysiology procedures such as ablation and diagnostics is increasing due to the aging population and the rise in lifestyle-related cardiac issues. Countries such as Brazil and Argentina are leading in this region due to improving healthcare facilities, increasing awareness of arrhythmia conditions, and an upshift in the economic conditions, allowing for better access to advanced healthcare. The Asia-Pacific region is projected to be the growing electrophysiology market globally, attributed to increasing healthcare expenditure, rising incidence of chronic diseases, and an expanding geriatric population. Countries such as China, Japan, and India are at the forefront, with governments initiating reforms to improve healthcare access and promote the adoption of advanced medical technologies. Europe significantly contributes to the EMEA electrophysiology market, driven by higher healthcare spending, a well-established healthcare system, and an increasing prevalence of cardiac diseases. Technological advancements and favorable reimbursement policies also support the market growth within this region. The Middle East and Africa are emerging with untapped potential, subject to improving economic conditions and government initiatives to modernize healthcare infrastructure.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Electrophysiology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Electrophysiology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Electrophysiology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Access Point Technologies EP, Inc., AccuPulse Medical Technology Co. Ltd., AtriCure, Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, CardioFocus, Inc., CathRx Ltd, Diagnosys LLC, ElectroPhysiology Frontiers S.p.A., GE HealthCare Technologies Inc., Imricor Medical Systems, Inc., Japan Lifeline Co., Ltd., Judges Scientific PLC, Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co., Ltd., Medical Device Business Services, Inc., Medtronic, Inc., Melys AFS Ltd, Microport Scientific Corporation, Nihon Kohden Corporation, Osypka AG, Siemens Healthcare GmbH, Teleflex Incorporated, and Warner Instruments, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Electrophysiology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Electrophysiology Market?
3. What are the technology trends and regulatory frameworks in the Electrophysiology Market?
4. What is the market share of the leading vendors in the Electrophysiology Market?
5. Which modes and strategic moves are suitable for entering the Electrophysiology Market?
the need for high-quality care in a more intimate and specialized setting